Understanding and controlling the molecular mechanisms of protein aggregation in mAb therapeutics

被引:17
作者
Pang, Kuin Tian [1 ,5 ]
Yang, Yuan Sheng [1 ]
Zhang, Wei [1 ]
Ho, Ying Swan [1 ]
Sormanni, Pietro [2 ]
Michaels, Thomas C. T. [3 ,4 ]
Walsh, Ian [1 ]
Chia, Sean [1 ]
机构
[1] ASTAR, Bioproc Technol Inst, Singapore, Singapore
[2] Univ Cambridge, Yusuf Hamied Dept Chem, Chem Hlth, Cambridge, England
[3] Swiss Fed Inst Technol, Inst Biochem, Dept Biol, Otto Stern Weg 3, CH-8093 Zurich, Switzerland
[4] Swiss Fed Inst Technol, Bringing Mat Life Initiat, Zurich, Switzerland
[5] Nanyang Technol Univ, Sch Chem Chem Engn & Biotechnol, Singapore, Singapore
基金
英国医学研究理事会;
关键词
Antibodies; Protein aggregation; Protein self-association; Developability; Chemical kinetics; MONOCLONAL-ANTIBODY AGGREGATION; NUCLEATED-POLYMERIZATION MODEL; COMPETING GROWTH; CONFORMATIONAL STABILITY; DRIVING FORCES; SINGLE-DOMAIN; IGG1; ANTIBODY; HIGH-PRESSURE; LOW PH; KINETICS;
D O I
10.1016/j.biotechadv.2023.108192
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In antibody development and manufacturing, protein aggregation is a common challenge that can lead to serious efficacy and safety issues. To mitigate this problem, it is important to investigate its molecular origins. This review discusses (1) our current molecular understanding and theoretical models of antibody aggregation, (2) how various stress conditions related to antibody upstream and downstream bioprocesses can trigger aggregation, and (3) current mitigation strategies employed towards inhibiting aggregation. We discuss the relevance of the aggregation phenomenon in the context of novel antibody modalities and highlight how in silico approaches can be exploited to mitigate it.
引用
收藏
页数:14
相关论文
共 50 条
[21]   Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses [J].
Verde, Enza Maria ;
Secco, Valentina ;
Ghezzi, Andrea ;
Mandrioli, Jessica ;
Carra, Serena .
CELLS, 2025, 14 (10)
[22]   Molecular Mechanisms of Aggregation of Canine SOD1 E40K Amyloidogenic Mutant Protein [J].
Wakayama, Kento ;
Kimura, Shintaro ;
Kobatake, Yui ;
Kamishina, Hiroaki ;
Nishii, Naohito ;
Takashima, Satoshi ;
Honda, Ryo ;
Kamatari, Yuji O. O. .
MOLECULES, 2023, 28 (01)
[23]   Molecular Peptide Grafting as a Tool to Create Novel Protein Therapeutics [J].
Komar, Anton A. .
MOLECULES, 2023, 28 (05)
[24]   Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics [J].
Li, Mingyue ;
Falk, Bradley T. ;
Lu, Xingyu ;
Schroder, Ryan ;
Mccoy, Mark ;
Xu, Wei ;
Yin, Daniel H. ;
Gindy, Marian E. ;
D'Addio, Suzanne M. ;
Su, Yongchao .
MOLECULAR PHARMACEUTICS, 2022, 19 (09) :3267-3278
[25]   Understanding and predicting protein misfolding and aggregation: Insights from proteomics [J].
Pallares, Irantzu ;
Ventura, Salvador .
PROTEOMICS, 2016, 16 (19) :2570-2581
[26]   Highly variable aggregation and glycosylation profiles and their roles in immunogenicity to protein-based therapeutics [J].
Sarsarshahi, Sina ;
Bhattacharya, Sanghati ;
Zacharias, Zeb R. ;
Kamel, Eman S. ;
Houtman, Jon C. D. ;
Nejadnik, Reza .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 114 (06)
[27]   A polymer physics perspective on driving forces and mechanisms for protein aggregation [J].
Pappu, Rohit V. ;
Wang, Xiaoling ;
Vitalis, Andreas ;
Crick, Scott L. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2008, 469 (01) :132-141
[28]   Advancements in understanding the molecular and immune mechanisms of Bartonella pathogenicity [J].
Jin, Xiaoxia ;
Gou, Yuze ;
Xin, Yuxian ;
Li, Jingwei ;
Sun, Jingrong ;
Li, Tingting ;
Feng, Jie .
FRONTIERS IN MICROBIOLOGY, 2023, 14
[29]   Molecular Dynamics Study of Protein Aggregation at Moving Interfaces [J].
Sarter, Tim ;
Friess, Wolfgang .
MOLECULAR PHARMACEUTICS, 2024, 21 (03) :1214-1221
[30]   Probing protein aggregation using discrete molecular dynamics [J].
Sharma, Shantanu ;
Ding, Feng ;
Dokholyan, Nikolay V. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 :4795-4807